Capital Intensity
Score how much of a company is physical plant, inventory, and equipment, whether that base is being maintained, and whether the shares have tangible backing.
Gilead Sciences Inc.
Physical assets are 12.5% of total assets, a light footprint. Capex is 0.20x depreciation while free cash flow yield is positive, which can mean an aging base that is still throwing off cash. ROIC is 25.4%, above an 8% cost-of-capital hurdle.
Fixed-asset turnover is 5.25x. Compare it with other names in the same basket.
Physical asset ratio
12.5%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
5.25x
Revenue per dollar of the physical asset base.
Capex / D&A
0.20x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
-€2.16
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
—
Price €138.90.
Fixed-charge coverage
3.40x
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
5.9%
Latest free cash flow divided by current market cap (€159.51B).
ROIC
25.4%
After-tax operating income over equity plus debt minus cash.
Operating income / net PP&E is 2.09x.
Footprint and return
Turnover and reinvestment
| Year | Physical | FAT | Capex/D&A | TBV/sh | Coverage | FCF | ROIC | EBIT/PP&E |
|---|---|---|---|---|---|---|---|---|
| 2022 | 11.1% | 4.98x | 0.35x | -€12.83 | 2.53x | €8.34B | 21.0% | 2.00x |
| 2023 | 11.4% | 5.10x | 0.22x | -€9.65 | 3.61x | €7.42B | 17.3% | 1.66x |
| 2024 | 12.1% | 5.31x | 0.19x | -€7.23 | 1.40x | €10.31B | 20.4% | 1.96x |
| 2025 | 12.5% | 5.25x | 0.20x | -€2.16 | 3.40x | €9.46B | 25.4% | 2.09x |
- Principal due is the current portion of debt.
Latest year inputs (2025)
Net PP&E: €5.61B
Inventory: €1.77B
Total assets: €59.02B
Goodwill: €8.31B
Intangibles: €16.98B
Liabilities: €36.41B
Tangible book: -€2.67B
Shares: 1,240,679,623
Revenue: €29.44B
Capex: €563.00M
D&A: €2.76B
EBITDA: €13.58B
Interest: €1.02B
Short-term debt: €2.81B
Free cash flow: €9.46B
Operating income: €11.70B
Invested capital: €40.07B
Tax rate: 13.1%